VarmX to present new data at the ISTH Congress
PharmaTimes
JULY 8, 2022
Preclinical data package details pharmacology and safety of VMX-C001
This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
PharmaTimes
JULY 8, 2022
Preclinical data package details pharmacology and safety of VMX-C001
European Pharmaceutical Review
FEBRUARY 27, 2024
While she is stepping down from her current role, Dame June shared that she still hopes to contribute] “to patient safety and public health in other ways” “It has been an enormous privilege to have led the MHRA through a time of change which is unprecedented in UK medical products regulation.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
MARCH 9, 2023
1 These substances “are pharmacologically and biologically active at low doses,” Dr Kishore Hotha, Global Head of Analytical Research & Development at Veranova, explained. ” Highly potent APIs are pharmacologically and biologically active compounds at low doses. What training is required for employees to handle HPAPIs safely?
European Pharmaceutical Review
SEPTEMBER 25, 2023
Key attributes of an enterprise resource planning (ERP) system required for drug traceability has been published in a Universal Journal of Pharmacy and Pharmacology paper. Specifically, it described how ERP systems clarify every aspect of operations in a business for drug serialisation compliance.
PharmExec
JULY 2, 2024
The Fast Track designation for INZ-701 was based nonclinical pharmacology data and preliminary safety and efficacy data from the ongoing Phase I/II trial of INZ-701 in adults with ABCC6 Deficiency.
European Pharmaceutical Review
OCTOBER 3, 2023
A paper published in Regulatory Toxicology and Pharmacology has proposed a consistent, health protective read-across methodology for extractables and leachables (E&Ls). The Extractables Leachables Safety Information Exchange (ELSIE) ’s safety team developed the methodology for generating permitted daily exposures (PDEs) for E&Ls.
European Pharmaceutical Review
MARCH 7, 2025
A paper published by the Drug Safety Research Unit (DSRU) in the British Journal for Clinical Pharmacology , has asserted the need for ongoing assessment of the safety and effectiveness of the Alzheimers drug lecanemab in the real-world clinical setting.
PM360
NOVEMBER 29, 2022
Drug labels hold value for life sciences companies because they are rich, extensive documents that can be used across labeling, regulatory, safety, and medical affairs. Typically, a drug label refers to any information provided with prescription drugs, as requested by regulators such as the U.S.
Pharmaceutical Technology
MAY 11, 2023
Rexulti has become the first and only pharmacological treatment to receive approval for this indication in the US. Brexpiprazole was found to be well-tolerated and its safety profile was consistent with its known safety profile in other indications.
pharmaphorum
JANUARY 17, 2023
Angion chalked up a series of trial failures for its hepatocyte growth factor (HGF) mimetic ANG-3777 over the last couple of years, and turned its attention to tyrosine kinase receptor inhibitor ANG-3070 in kidney diseases and fibrotic disorders, before abandoning the drug due to safety concerns in the middle of 2022.
pharmaphorum
AUGUST 16, 2022
The highly anticipated Lipid Nanoparticle Immunogenicity & Toxicity Summit takes place this December to unite 80+ senior leaders as the definitive meeting for clinical pharmacology , immunogenicity , bioanalytical development leaders to stay at the forefront, arming you with practical takeaways and lessons learned.
European Pharmaceutical Review
DECEMBER 11, 2023
mAbs have well-established safety profiles, high specificity and affinity and long half-lives – they have been used in drug development for more than 30 years. Known linkers in the RNA field are used to bond together the two pharmacologically active molecular entities and can be applied to multiple oligonucleotide modalities.
Pharmaceutical Representative Training
JANUARY 11, 2021
Next, pharma reps need to have a strong foundation in basic science and pharmacology. Pharmacology is the science of medications and the role they play in the body. A great way to distinguish yourself from other candidates is to complete the Pharmaceutical Representative Certification (PRC) program.
Contrarian Sales Techniques
FEBRUARY 25, 2023
During my pharmacology class, I learned that there are no safe drugs, only safe patients. Clinical studies play an essential role in determining the safety and efficacy of new drugs before they can be approved for the public. This includes potential side effects or adverse reactions to medications.
Pharmaceutical Technology
AUGUST 16, 2022
Recently, Q32 concluded a Phase I clinical trial to evaluate the pharmacokinetics, pharmacodynamics and safety of ADX-914, which showed a pharmacological effect on T cells in healthy subjects. antibody, ADX-914 re-regulates adaptive immune function by hindering IL-7 and TSLP-facilitated signalling.
European Pharmaceutical Review
JULY 27, 2023
Pharmacological therapies mainly address symptoms and unfortunately a significant number of patients do not respond adequately, progressing to congestive heart failure and eventually needing a heart transplant. Despite these trials varying in design, they confirmed the feasibility and safety of the procedure. Frontiers in Pharmacology.
Impetus Digital
AUGUST 2, 2024
To avoid compliance issues , it is essential to keep up with new regulatory changes, including updated reporting guidelines and safety requirements. Regulatory Compliance Regulatory frameworks are continuously evolving in the pharmaceutical industry.
Pharmaceutical Technology
FEBRUARY 8, 2023
Still, Blank suggested that companies enroll the patient population that is most likely to benefit, because early phase studies contain the most safety risks. Blank acknowledged that in many cases, an exclusively paediatric patient population could lead to difficulties with drawing consent for early phase trials.
Pharmaceutical Technology
SEPTEMBER 14, 2022
Victoza, Copaxone, Lupron, Zoladex, Sandostatin, and Somatuline are some of the popularly marketed peptide API therapeutic drugs while more than 600 peptide-based pharmacological leads are being investigated worldwide, across various phases of development.
European Pharmaceutical Review
SEPTEMBER 22, 2023
7 It is currently being evaluated in a Phase Ib/IIa clinical study, demonstrating to date a good safety profile. While favourable safety has been reported up to the Phase II, the relevance of targeting the C-terminal portion of Abeta still needs to be confirmed.
Legacy MEDSearch
AUGUST 25, 2022
The primary safety endpoint is a performance goal for device and procedure related adverse events at 30 days. The FDA-approved randomized IDE trial has been designed to validate the safety and effectiveness of PiCSO.” Major adverse cardiac events and heart failure endpoints will be captured acutely and for up to 3 years.
Pharmaceutical Representative Training
JUNE 22, 2024
The pharmaceutical industry is one of the most heavily regulated sectors due to the direct impact of its products on public health and safety. Several factors contribute to the stringent regulatory environment: Patient Safety: Ensuring that the pharmaceutical products are safe and effective is a crucial aspect. link] Reuters.
European Pharmaceutical Review
JULY 18, 2024
This covers nonclinical drug safety, translational and clinical pharmacology, drug metabolism and pharmacokinetics (DMPK) and pharmacometrics. She also heads three of Ipsen’s specialised functions that support the entire pipeline from discovery through to lifecycle management.
European Pharmaceutical Review
MARCH 11, 2024
With therapeutic expertise in HIV, hepatology and rare diseases, Sherene has additional expertise in clinical pharmacology and drug safety. Sherene has worked in the healthcare sector for more than 20 years, including in several leadership roles at GSK.
European Pharmaceutical Review
FEBRUARY 13, 2025
Yet these innovations pose great challenges to bioanalytical techniques and safety evaluations. For instance, GalNac-siRNA degradation may produce pharmacologically active metabolites with partial complementarity to the detection probes used in other methods. Safety of Antisense Oligonucleotide And Sirna-Based Therapeutics.
pharmaphorum
DECEMBER 20, 2022
That’s impressive, as it has proved exceedingly difficult for pharmacological therapies to show an impact on fibrosis in prior studies. Similarly, a one-stage or greater improvement in liver fibrosis was seen in 24% and 26% of the resmetirom groups, respectively, versus 14% of patients taking placebo.
Medgadget
MAY 2, 2023
While for other patients the possible adverse side effects from medication may prevent them from finding pharmacological therapies effective. During this time, two additional studies ended successfully and were published, further validating the clinical safety and effectiveness.
European Pharmaceutical Review
JULY 25, 2024
Palframan received his BSc in pharmacology at King’s College London and his PhD in immunology at Imperial College London. What should the industry prioritise to advance the gene therapy field? Roger was a Wellcome Trust Postdoctoral Research Fellow at Harvard Medical School.
Infuse Medical
DECEMBER 17, 2024
These animations let businesses more successfully show safety, benefits, and product functionality than with more conventional techniques. We create animations that appeal to the target audience from depicting pharmacological processes of action to elucidating complicated medical gadgets.
Pharmaceutical Technology
FEBRUARY 13, 2023
As well as presenting an acceptable PK profile and demonstrating in-vivo efficacy, it becomes important to show that the candidate drug has a good safety pharmacology margin with an acceptable drug-drug interaction (DDI) profile.
European Pharmaceutical Review
JANUARY 13, 2025
At Chiesi, we are conducting the same rigour in terms of safety and bioavailability studies as we would for a new molecule, navigating regulatory and reimbursement discussions, and having to build entirely new manufacturing sites and capabilities. Pulmonary Pharmacology & Therapeutics. 2024; 85: 1-9. Internet] The Aerosol Society.
Quantified
JUNE 28, 2022
Equally, certification can support compliance, fair balance and consistent inclusion of important safety information. Mark holds degrees in Medicine and Pharmacology from the University of Manchester and studied business at Manchester Business School.
European Pharmaceutical Review
JULY 13, 2023
While this is essential in the interrogation of novel compounds for which we know very little about their efficacy and safety, it is also true that some biomedical research is highly wasteful. An observational study of safety and clinical outcome measures across patient groups in the United Kingdom Medical Cannabis Registry.
pharmaphorum
SEPTEMBER 9, 2022
Prior to the launch of those drugs, pharmacological therapy for obesity was something of a backwater, constrained by tolerability and safety issues for older, generic drugs, and lacklustre take-up of newer therapies with limited efficacy. Novo Nordisk recently predicted its obesity sales could reach $3.7 billion in 2025.
European Pharmaceutical Review
MAY 2, 2023
By collaborating with several stakeholders and authorities, multiple stages of development can take place concurrently to speed up R&D without compromising safety protocols. The COVID-19 blueprint has shown a way forward. Previously, he spent more than 10 years at Roche in multiple positions within medical affairs.
Clarivate
OCTOBER 7, 2024
They became integral to physiological and pharmacological research during the 19th century and started to be systematically used for drug development during the 20th century. Since then, animal-based testing has been the gold standard for establishing a drug’s safety and efficacy. Clinical Pharmacology and Therapeutics, 104(6), pp.
Legacy MEDSearch
DECEMBER 12, 2022
” Clinical studies have shown Nerivio to be as effective as standard of care pharmacological options for acute migraine treatment. Theranica recently published topline results of a pivotal trial demonstrating the efficacy and safety of Nerivio® also for the preventive treatment of migraine, currently under FDA review.
European Pharmaceutical Review
JULY 19, 2023
The data “are compelling, particularly the significant improvements observed in both depressive and anhedonic symptoms,” stated Dr Roger S McIntyre, FRCPC, Professor of psychiatry and pharmacology, University of Toronto and Executive Director of the Brain and Cognition Discovery Foundation in Toronto, Canada.
pharmaphorum
DECEMBER 22, 2022
Pfizer reckons the pharmacology of etrasimod – including its engagement with S1P 1, 4 and 5 receptor subtypes – differentiates the drug from its rival, which binds mainly to subtypes 1 and 5. “We believe that etrasimod, if approved, has the potential to be a best-in-class, first-line advanced therapy.”
Pharmaceutical Technology
AUGUST 8, 2022
But the pharmacology to quantify adherence also depends on race, gender, weight, and other factors. In addition to ensuring safety and data transparency, it is important that patient access is not affected, says Haga.
European Pharmaceutical Review
JULY 4, 2024
The FDA’s role in the regulation of botanical drug products includes an assessment of their safety and efficiency 5 but insufficient evidence for efficacy is one of the most common reasons why new drug candidates fail to reach this step. 10,12 The THR scheme is also limited to products used for oral or external use and/or inhalation.
Pharmaceutical Technology
OCTOBER 10, 2022
Despite the recognized need and demand for options to treat female sexual dysfunction, several safety and access issues associated with the use of available options. All this development comes in the backdrop of a wider sense of stigma against the use of pharmacologic options for female sexual function, says Kingsberg.
European Pharmaceutical Review
NOVEMBER 13, 2024
New clinical trial findings show that twice-yearly lenacapavir for HIV pre-exposure prophylaxis (PrEP) had high efficacy and safety in a diverse group of participants. This data provides the first in-depth insight into full results of Gilead Sciences pivotal Phase III PURPOSE 2 trial.
Pharmaceutical Technology
FEBRUARY 17, 2023
In January, amidst calls to improve patient safety by optimizing licensed drug formulations, the FDA released a draft guidance that signalled a departure from the most commonly used method of identifying a new therapy’s ideal dosage. The clinical pharmacology knowledge also isn’t present at smaller companies, he adds.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content